FORMELA JEAN FRANCOIS — SEC Form 4 filings
SEC reporting owner CIK 1030575. 12 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-04-23 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 24 legs across 7 filings — 363,889 shares, $5,160,283 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
- Largest priced transaction: sale of 101,579 shares @ $14.25 ($1,447,501) in Korro Bio, Inc., filed 2026-06-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Korro Bio, Inc. (KRRO) | Director | 11 | — | 24 legs · 363,889 sh · $5,160,283 | 4 |
| Ikena Oncology, Inc. (IKNA) | Director | 1 | — | — | 1 |
Form 4 filings — FORMELA JEAN FRANCOIS
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | Korro Bio, Inc. (KRRO) | Sale (S): 8,450 @ $13.99 · Sale (S): 1,750 @ $13.99 · Sale (S): 31,888 @ $14.12 · Sale (S): 6,602 @ $14.12 | EDGAR |
| 2026-08-28 | 4 | Korro Bio, Inc. (KRRO) | Sale (S): 249 @ $13.96 · Sale (S): 51 @ $13.96 | EDGAR |
| 2026-08-21 | 4 | Korro Bio, Inc. (KRRO) | Sale (S): 23,584 @ $14 · Sale (S): 4,884 @ $14 | EDGAR |
| 2026-08-13 | 4 | Korro Bio, Inc. (KRRO) | Sale (S): 1,775 @ $13.96 · Sale (S): 368 @ $13.96 | EDGAR |
| 2026-07-07 | 4 | Korro Bio, Inc. (KRRO) | Sale (S): 85,955 @ $14.03 · Sale (S): 14,745 @ $14.03 · Sale (S): 817 @ $13.96 · Sale (S): 8,506 @ $13.96 | EDGAR |
| 2026-06-24 | 4 | Korro Bio, Inc. (KRRO) | Sale (S): 3,382 @ $13.95 · Sale (S): 580 @ $13.95 · Sale (S): 101,579 @ $14.25 · Sale (S): 17,426 @ $14.25 · Sale (S): 40,679 @ $14.60 · Sale (S): 666 @ $14.98 · +2 more | EDGAR |
| 2026-06-11 | 4 | Korro Bio, Inc. (KRRO) | Grant/award (A): 14,677 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Korro Bio, Inc. (KRRO) | Sale (S): 2,441 @ $13.95 · Sale (S): 419 @ $13.95 | EDGAR |
| 2025-06-12 | 4 | Korro Bio, Inc. (KRRO) | Grant/award (A): 6,010 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | Korro Bio, Inc. (KRRO) | Grant/award (A): 5,190 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Ikena Oncology, Inc. (IKNA) | Grant/award (A): 17,520 (derivative) @ $0 | EDGAR |
| 2024-04-23 | 4 | Korro Bio, Inc. (KRRO) | Grant/award (A): 17,857 @ $56 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1030575 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →